CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


biochemical analysisWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D010195 Pancreatitis NIH 1.00

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0001733 Pancreatitis HPO 1.00

There is one clinical trial.

Clinical Trials


1 Pancreatic Injury in Patients With COVID-19 Disease

Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common. In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury in the course of COVID 19 disease.

NCT04433754 Pancreatitis Other: biochemical analysis
MeSH:Pancreatitis
HPO:Pancreatitis

Primary Outcomes

Description: To evaluate the frequency of presence of fever in patients with and without pancreatic injury

Measure: to compare presence of fever in patients with and without pancreatic injury

Time: 3 month

Description: To evaluate the frequency of presence of dyspnea in patients with and without pancreatic injury

Measure: to compare presence of dyspnea in patients with and without pancreatic injury

Time: 3 month

Description: CRP levels will be compared in patients with and without pancreatic injury

Measure: To compare cRP levels in patients with and without pancreatic injury

Time: 3 month

Description: D-Dimer levels will be compared in patients with and without pancreatic injury

Measure: To compare d-dimer levels in patients with and without pancreatic injury

Time: 3 month


Related HPO nodes (Using clinical trials)